Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated just now
Peer-reviewedCC BYPharmaceutical biology

Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.

Related

  1. Inclisiran attenuates myocardial ischemia/reperfusion injury by inhibiting macrophage M1 polarization
    Ding-Yu Shi, Zi-Zhuo Li, Jun-Qin Bai +8
    ApoptosisPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicinePMC
  2. Intraarticular Injection of Infliximab-Loaded Thermosensitive Hydrogel Alleviates Pain and Protects Cartilage in Rheumatoid Arthritis [Retraction].
    Journal of pain researchPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Myocardial Ischemia-Reperfusion Injury: Molecular Mechanisms and Innovative Therapeutic Strategies
    Dong Zhang, Xiaoting Yang, Shengyu Gong +4
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. AN INTEGRATED HEART-ON-A-CHIP NAM RESOLVES DISTINCT CLINICAL PHENOTYPES OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
    Khanh Tran, Ashley Roselynn Vincent, Caroline Whitmer +2
    bioRxivPreprintAll rights reservedFull textPhysiologybioRxivPMC
  5. Cardiac unloading via a transvalvular pump prevents arrhythmias following myocardial ischemia / reperfusion by preserving coronary microcirculation and cardiomyocyte nanostructure
    M. Ammon, P. H. Melo, K. Nowak +8
    bioRxivPreprintAll rights reservedFull textPhysiologybioRxiv
BibTeX
@article{anon2026statement,
  title = {{Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.}},
  journal = {Pharmaceutical biology},
  year = {2026},
  month = oct,
  doi = {10.1080/13880209.2026.2753396},
  url = {https://europepmc.org/article/MED/42951682},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Statement of Retraction: Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway.
PY  - 2026
DA  - 2026/10/28
JO  - Pharmaceutical biology
DO  - 10.1080/13880209.2026.2753396
UR  - https://europepmc.org/article/MED/42951682
SN  - 1388-0209
SN  - 1744-5116
ER  -